Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Survey of current approaches to non-diagnostic fine-needle aspiration from solid thyroid nodules.

Brito JP, Castro MR, Dean DS, Fatourechi V, Stan M.

Endocrine. 2015 Aug;49(3):745-51. doi: 10.1007/s12020-015-0539-4. Epub 2015 Feb 4.

PMID:
25649761
2.

Medical management of extrathyroidal manifestation of graves disease.

Fatourechi V.

Endocr Pract. 2014 Dec;20(12):1333-44. doi: 10.4158/EP14281.RA.

PMID:
25370325
3.

Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyroglobulin-positive radioactive iodine-negative whole-body scans.

Fatourechi V, Morris JC 3rd, Sebo TJ.

Thyroid. 2014 Sep;24(9):1432-4. doi: 10.1089/thy.2014.0010. Epub 2014 Jul 14. No abstract available.

PMID:
24934079
4.

Extrathyroidal manifestations of Graves' disease: a 2014 update.

Bartalena L, Fatourechi V.

J Endocrinol Invest. 2014 Aug;37(8):691-700. doi: 10.1007/s40618-014-0097-2. Epub 2014 Jun 10. Review.

PMID:
24913238
5.

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C; Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium.

J Clin Endocrinol Metab. 2014 May;99(5):1687-93. doi: 10.1210/jc.2013-3713. Epub 2014 Feb 25.

6.

Symptomatic amyloid goiters: report of five cases.

Law JH, Dean DS, Scheithauer B, Earnest F 4th, Sebo TJ, Fatourechi V.

Thyroid. 2013 Nov;23(11):1490-5. doi: 10.1089/thy.2012.0431. Epub 2013 Sep 19.

PMID:
23544771
7.

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.

Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C.

J Oncol Pract. 2012 May;8(3 Suppl):e1s-5s. doi: 10.1200/JOP.2011.000496.

8.

Thyroid dermopathy and acropachy.

Fatourechi V.

Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):553-65. doi: 10.1016/j.beem.2011.10.001. Epub 2012 May 22. Review.

PMID:
22863396
9.

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.

Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C.

Am J Manag Care. 2012 May 1;18(5):e162-7.

10.

Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.

Chindris AM, Diehl NN, Crook JE, Fatourechi V, Smallridge RC.

J Clin Endocrinol Metab. 2012 Aug;97(8):2714-23. doi: 10.1210/jc.2011-3017. Epub 2012 May 25.

PMID:
22639286
11.

Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008.

Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V.

Thyroid. 2011 Jul;21(7):765-72. doi: 10.1089/thy.2010.0453. Epub 2011 May 13.

PMID:
21568724
12.

Graves' disease after unilateral Riedel's thyroiditis.

McIver B, Fatourechi MM, Hay ID, Fatourechi V.

J Clin Endocrinol Metab. 2010 Jun;95(6):2525-6. doi: 10.1210/jc.2009-2609. No abstract available.

PMID:
20525902
13.

Subclinical hypothyroidism: an update for primary care physicians.

Fatourechi V.

Mayo Clin Proc. 2009;84(1):65-71. doi: 10.1016/S0025-6196(11)60809-4. Review.

14.

Graves ophthalmopathy: continuing quest in search of initiating factors and new therapies.

Fatourechi V.

Endocr Pract. 2008 May-Jun;14(4):412-4. No abstract available.

PMID:
18558590
15.

Upper limit of normal serum thyroid-stimulating hormone: a moving and now an aging target?

Fatourechi V.

J Clin Endocrinol Metab. 2007 Dec;92(12):4560-2. No abstract available.

PMID:
18056780
16.

Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.

Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V.

J Clin Endocrinol Metab. 2007 Jan;92(1):82-7. Epub 2006 Oct 31.

PMID:
17077133
17.

Spectrum of malignant somatostatin-producing neuroendocrine tumors.

Moayedoddin B, Booya F, Wermers RA, Lloyd RV, Rubin J, Thompson GB, Fatourechi V.

Endocr Pract. 2006 Jul-Aug;12(4):394-400.

PMID:
16901794
18.

Primary squamous cell carcinoma of the thyroid: report of ten cases.

Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V.

Thyroid. 2006 Jan;16(1):89-93.

PMID:
16487020
19.

Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B.

Arch Neurol. 2006 Feb;63(2):197-202.

PMID:
16476807
20.

Pretibial myxedema: pathophysiology and treatment options.

Fatourechi V.

Am J Clin Dermatol. 2005;6(5):295-309. Review.

PMID:
16252929
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk